Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Aims & Scope

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs ...read more

  • ISSN (Print): 1568-0088
  • ISSN (Online): 1875-5917
  • Volume: 5
  • Issues: 4, 2005
Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 5, Issue 4, 2005


Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs

Pp: 357-364

Author(s): M. E. Ganapathy and V. Ganapathy

DOI: 10.2174/1568005310505040357

Augmenting T Helper Cell Immunity in Cancer

Pp: 365-371

Author(s): K. L. Knutson and M. L. Disis

DOI: 10.2174/1568005310505040365

Management of Liver Disease in Thalassemia: Main Drug Targets for a Correct Therapy

Pp: 373-378

Author(s): G. C. D. Vecchio, A. Nigro, P. Giordano and D. De Mattia

DOI: 10.2174/1568005310505040373

Molecular Basis of Therapeutic Strategies for Breast Cancer

Pp: 379-396

Author(s): Jing Huang, Xiaodong Li, Russell Hilf, Robert A. Bambara and Mesut Muyan

DOI: 10.2174/1568005310505040379

The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface

Pp: 397-411

Author(s): A. M. Paterson, S. F. Yates, K. F. Nolan and H. Waldmann

DOI: 10.2174/1568005310505040397

Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity

Pp: 413-423

Author(s): B. Crimeen-Irwin, K. Scalzo, S. Gloster, P. L. Mottram and M. Plebanski

DOI: 10.2174/1568005310505040413

Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation

Pp: 423-437

Author(s): P. G. Quinn and D. Yeagley

DOI: 10.2174/1568005310505040423

Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms

Pp: 465-475

Author(s): Xiaoxia Zhou, Peter Schmidtke, Fred Zepp and Claudius U. Meyer

DOI: 10.2174/1568005310505040465